Advertisement
Research Article Free access | 10.1172/JCI114243
Molecular Genetics Section, National Cancer Institute, Bethesda, Maryland 20892.
Find articles by El-Badry, O. in: JCI | PubMed | Google Scholar
Molecular Genetics Section, National Cancer Institute, Bethesda, Maryland 20892.
Find articles by Romanus, J. in: JCI | PubMed | Google Scholar
Molecular Genetics Section, National Cancer Institute, Bethesda, Maryland 20892.
Find articles by Helman, L. in: JCI | PubMed | Google Scholar
Molecular Genetics Section, National Cancer Institute, Bethesda, Maryland 20892.
Find articles by Cooper, M. in: JCI | PubMed | Google Scholar
Molecular Genetics Section, National Cancer Institute, Bethesda, Maryland 20892.
Find articles by Rechler, M. in: JCI | PubMed | Google Scholar
Molecular Genetics Section, National Cancer Institute, Bethesda, Maryland 20892.
Find articles by Israel, M. in: JCI | PubMed | Google Scholar
Published September 1, 1989 - More info
Insulin-like growth factor II (IGF-II) mRNA was increased in two of eight neuroblastomas and in eight of eight pheochromocytomas, tumors of the adrenal medulla that occur in childhood and adulthood, respectively. RNA encoding the type I IGF receptor, the receptor thought to mediate the mitogenic effects of IGF-I and IGF-II, also was uniformly expressed in these cells. To assess the role of IGF-II in the growth of these tumor cells, we have used the SK-N-AS cultured neuroblastoma cell line, which can be continuously propagated in mitogen-free medium, as a model system. Our results strongly suggest that IGF-II, synthesized by SK-N-AS cells and acting through type I IGF receptors, contributes to the autonomous growth of this tumor cell line. (a) SK-N-AS cells synthesized large amounts of IGF-II RNA and secreted greater than 50 ng/ml of IGF-II (as determined by specific radioimmuno- and radioreceptor assays). Little, if any, IGF-I RNA or immunoreactive IGF-I were detected. (b) SK-N-AS cells possess type I IGF receptors. (c) Exogenous IGF-I and IGF-II stimulated DNA synthesis in SK-N-AS cells, and this stimulation was abolished by a blocking antibody to the type I IGF receptor. (d) This anti-receptor antibody also abolished the multiplication of SK-N-AS cells in the absence of added mitogens. We conclude that IGF-II is an autocrine growth factor for SK-N-AS cells and suggest that this mechanism may contribute to the growth of some adrenal medullary tumors.
Images.